James E Norton Selected Research

Complement Membrane Attack Complex (Membrane Attack Complex)

7/2017

Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Norton Research Topics

Disease

19	Rhinosinusitis 01/2023 - 04/2013
16	Nasal Polyps (Nasal Polyp) 01/2023 - 04/2013
5	Asthma (Bronchial Asthma) 01/2021 - 03/2015
4	Inflammation (Inflammations) 01/2023 - 04/2013
3	Polyps 11/2022 - 01/2017
3	Neoplasms (Cancer) 03/2021 - 01/2019
3	Infections 01/2016 - 08/2013
2	Hypersensitivity (Allergy) 03/2024 - 03/2015
2	Eosinophilia 01/2017 - 09/2015
1	Anaphylaxis (Anaphylactic Shock) 03/2024
1	Carcinoma (Carcinomatosis) 03/2024
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Sepsis (Septicemia) 02/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Bacterial Infections (Bacterial Infection) 12/2017
1	Eosinophilic Esophagitis 09/2015
1	Airway Remodeling 04/2015
1	Rabies (Hydrophobia) 08/2013
1	Lung Injury 09/2007
1	Pulmonary Edema 09/2007

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2014
5	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2013
3	CytokinesIBA 02/2023 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 09/2017
3	FibrinIBA 11/2022 - 12/2019
3	VaccinesIBA 03/2021 - 08/2013
3	AntibodiesIBA 07/2017 - 04/2013
3	Messenger RNA (mRNA)IBA 01/2017 - 09/2015
2	Oncostatin MIBA 01/2023 - 06/2017
2	Cyclooxygenase 1IBA 01/2021 - 01/2021
2	AllergensIBA 06/2017 - 09/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 09/2007
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2015
1	acalabrutinibIBA 03/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024
1	LipidsIBA 02/2023
1	Angiopoietin-2IBA 02/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	SubtilisinIBA 01/2023
1	Thymic Stromal LymphopoietinIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 11/2022
1	RetinoidsIBA 11/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	IntegrinsIBA 12/2020
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	Immunoglobulin D (IgD)IBA 12/2017
1	Complement System Proteins (Complement)IBA 07/2017
1	Staphylococcal Protein A (Protein A)IBA 07/2017
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 07/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 06/2017
1	Interleukin-13IBA 01/2017
1	EpiregulinIBA 01/2017
1	Chemokine CCL26IBA 01/2017
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2017
1	Proton Pump InhibitorsIBA 01/2017
1	LigandsIBA 01/2017
1	Poly I-CIBA 01/2016
1	Filaggrin ProteinsIBA 05/2015
1	Toll-Like Receptor 2IBA 04/2015
1	AutoantigensIBA 03/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014
1	OvalbuminIBA 08/2013
1	Neutralizing AntibodiesIBA 08/2013
1	HLA-DR Antigens (HLA-DR)IBA 08/2013
1	Interleukin-2 (IL2)IBA 08/2013
1	EndotoxinsIBA 09/2007

Therapy/Procedure

3	Therapeutics 02/2023 - 01/2019
1	Immunotherapy 03/2021
1	Immunomodulation 01/2021
1	Transplantation 01/2019